Claris Ventures Secures First Closing for Biotech Fund II
Funding | Apr 23, 2025 | CDP Venture Capital
Claris Ventures has announced the first closing of its new venture capital fund, Claris Biotech II, which aims to raise 100 million euros to support early-stage biotech startups emerging from Italy's research ecosystem. The fund follows the success of their first fund, which launched in 2020 and raised 85 million euros, financing ten companies focused on therapeutic areas such as oncology and rare diseases. Claris Biotech II will continue to make selective investments with the goal of helping startups reach early clinical validation. Major institutional investors in the new fund include CDP Venture Capital and the European Investment Fund as they continue to support life sciences innovation. In addition to the first closing, Claris has announced the addition of Giulia Vestri as a new partner, bringing her expertise in biotech business development to the team.
Sectors
- Biotech
- Venture Capital
- Life Sciences
Geography
- Italy – Claris Ventures is investing in Italian biotech startups, emanating from the Italian research ecosystem, highlighting the country's significant role.
- Europe – Involvement of European Investment Fund indicates the broader European context, with investments impacting Europe-wide life sciences innovation.
Industry
- Biotech – The focus of the article is on Claris Ventures' new fund dedicated to supporting biotech startups, which is central to the biotechnology industry.
- Venture Capital – Claris Ventures, the article's main focus, is a venture capital firm aiming to invest in early-stage biotech companies.
- Life Sciences – The article discusses investment in life sciences, specifically biotech, as major investors like CDP Venture Capital prioritize this sector.
Financials
- 100000000 – The fundraising target for Claris Biotech II.
- 85000000 – The total funds raised by Claris Ventures' first fund in 2020.
- 170000000 – The total capital raised by the portfolio companies supported by the first fund.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Claris Ventures | Fund Manager | Company | Claris Ventures is launching its second biotech-focused fund, Claris Biotech II. |
| CDP Venture Capital | Investor | Company | A major investor in Claris Biotech II, demonstrating their commitment to supporting life sciences innovation. |
| European Investment Fund (EIF) | Investor | Company | Part of the EIB Group, the EIF is investing in Claris Biotech II to support the biotech sector in Europe. |
| Giulia Vestri | Partner | Person | Giulia Vestri has been added as a Partner at Claris Ventures to enhance the team's expertise in biotech development. |